# SpecGx LLC – FDA Inspection, Jun 12, 2014

Source: https://www.keypedia.com/records/fda_inspections/specgx-llc/4735a37b-90ed-4290-88c9-a2ec11c40e7d
Source feed: FDA_Inspections

> FDA inspection 883175 of SpecGx LLC, June 12, 2014. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 883175
- Company Name: SpecGx LLC
- Inspection Date: 2014-06-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4ef58d63-e23f-4c06-9834-380b593fbb90)
- FDA Inspection 1163660 - 2022-02-11
- [FDA Inspection 1103208 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/specgx-llc/75d21b61-9c72-4784-bf5f-16c5e92499a8)
- [FDA Inspection 994662 - 2016-11-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/6828282d-6ad1-439a-b2b4-d13d284884a0)
- FDA Inspection 834018 - 2013-05-24

Company: https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
